2013
microRNAs in nociceptive circuits as predictors of future clinical applications
KRESS, Michaela; Alexander HÜTTENHOFER; Marc LANDRY; Rohini KUNER; Alexandre FAVEREAUX et al.Základní údaje
Originální název
microRNAs in nociceptive circuits as predictors of future clinical applications
Autoři
KRESS, Michaela; Alexander HÜTTENHOFER; Marc LANDRY; Rohini KUNER; Alexandre FAVEREAUX; David GREENBERG; Josef BEDNAŘÍK; Paul HEPPENSTALL; Florian KRONENBERG; Marzia MALCANGIO; Heike RITTNER; Nurcan ÜÇEYLER; Zlatko TRAJANOSKI; Peter MOURITZEN; Frank BIRKLEIN; Claudia SOMMER a Hermona SOREQ
Vydání
Frontiers in Molecular Neuroscience, Lausanne, Frontiers Research Foundation, 2013, 1662-5099
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30000 3. Medical and Health Sciences
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/13:00071637
Organizační jednotka
Lékařská fakulta
UT WoS
Klíčová slova anglicky
Antagomir; Biomarker; Chronic pain; miRNA expression patterns; miRNA polymorphisms; miRNA-based analgesic; miRNA-based diagnostics; Polymorphism
Příznaky
Recenzováno
Změněno: 29. 4. 2014 15:04, Ing. Mgr. Věra Pospíšilíková
Anotace
V originále
Neuro-immune alterations in the peripheral and central nervous system play a role in the pathophysiology of chronic pain, and non-coding RNAs - and microRNAs (miRNAs) in particular - regulate both immune and neuronal processes. Specifically, miRNAs control macromolecular complexes in neurons, glia and immune cells and regulate signals used for neuro-immune communication in the pain pathway. Therefore, miRNAs may be hypothesized as critically important master switches modulating chronic pain. In particular, understanding the concerted function of miRNA in the regulation of nociception and endogenous analgesia and defining the importance of miRNAs in the circuitries and cognitive, emotional and behavioral components involved in pain is expected to shed new light on the enigmatic pathophysiology of neuropathic pain, migraine and complex regional pain syndrome. Specific miRNAs may evolve as new druggable molecular targets for pain prevention and relief. Furthermore, predisposing miRNA expression patterns and inter-individual variations and polymorphisms in miRNAs and/or their binding sites may serve as biomarkers for pain and help to predict individual risks for certain types of pain and responsiveness to analgesic drugs. miRNA-based diagnostics are expected to develop into hands-on tools that allow better patient stratification, improved mechanism-based treatment, and targeted prevention strategies for high risk individuals.